Is DXCM a good stock to buy? We came across a bullish thesis on DexCom, Inc. on Part-Time Compounder’s Substack by Francesco Ferrari. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.’s share was trading at $64.62 as of April 20th. DXCM’s trailing and forward P/E were 30.92 and 25.91, respectively according to Yahoo Finance.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose...
